Kardium Lands $31M Canadian Gov’t Funding to Expand Globe PFA Manufacturing

Kardium has received funding of up to $31.25 million from the Government of Canada through its Strategic Response Fund (SRF).

The funds will be used in Kardium’s $125 million project to expand the capabilities at its Vancouver, BC manufacturing site. The investment will expand the company’s Vancouver cleanroom to support increased manufacturing capacity while retaining key expertise, intellectual property, and jobs in Canada.

The company’s Globe system, an integrated high-density cardiac mapping and ablation system for cardiac pulsed field ablation (PFA), earned Health Canada approval last month. It gained U.S. Food and Drug Administration (FDA) 510(k) clearance about a year ago.

PFA procedures with Globe allow single-shot pulmonary vein isolation (PVI) and customizable, targeted ablation using one catheter.

Comments from Kardium and Canadian Government

Kevin Chaplin, CEO: “Kardium is proud to be developing and manufacturing our innovative medical technology here in British Columbia. The Government of Canada’s funding is an important step in our continued growth and will help us expand our manufacturing capabilities as we bring our technology to more physicians and patients around the world.”

Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions: “British Columbia is emerging as a global hub for medical innovation, home to companies like Kardium that are developing new technologies with the potential to improve lives around the world. By supporting Kardium’s expansion, the Government of Canada is strengthening Canada’s advanced manufacturing capacity, creating high-value jobs, and ensuring British Columbia remains at the forefront of innovation in the medical sector.”